Enzyme inhibitor tunicamycin V prepared via a Büchner-Curtius-Schlotterbeck-type reaction

Enzyme-responsive compound as a source of signaling molecules

Enzymes from the branched-chain amino acid biosynthesis pathway as targets for drug development

Insights into the biosynthesis of guanitoxin enable environmental detection

Halogenation reactions enabled by a nitrogen-centered radical precursor

Useful reaction for the synthesis of drug precursors

Polyester filter media coated with CuO nanoparticles

Highlights from Chemistry Europe, ACES, and GDCh journals

Derivatives of macrocyclic depsipeptides with promising antitumor activities

Gisbert Schneider honored for pioneering work on artificial intelligence approaches in drug design